A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation (Q44247543)

1 December 2017

A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation (English)

1 reference

1 December 2017

0 references

Michal Irony-Tur-Sinai

1

1 reference

1 December 2017

Israel Vlodavsky

2

1 reference

1 December 2017

Shmuel A Ben-Sasson

3

1 reference

1 December 2017

Florence Pinto

4

1 reference

1 December 2017

Camille Sicsic

5

1 reference

1 December 2017

Talma Brenner

6

1 reference

1 December 2017

1 January 2003

1 reference

Journal of the Neurological Sciences

1 December 2017

1 reference

1 December 2017

206

1 reference

1 December 2017

49-57

1 reference

1 December 2017

1

1 reference

Immunological aspects of demyelinating diseases

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

B cells and antibodies in CNS demyelinating disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Proteoglycans: structures and interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

A neuronal cell surface heparan sulfate proteoglycan is required for dorsal root ganglion neuron stimulation of Schwann cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Effect of Heparin on Mixed Lymphocyte Cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Inhibition of mouse natural killer cytotoxicity by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Inhibition of phospholipase A2 by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Inhibition of human secretory class II phospholipase A2 by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Treatment of central nervous system inflammation with inhibitors of basement membrane degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Astrocytes, oligodendrocytes, and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Interaction between nitric oxide and prostaglandin synthesis in the acute phase of allergic conjunctivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Lipid mediators in inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Phospholipase A2 and its role in brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

A longitudinal study of the prostaglandin content of central nervous system tissues from guinea pigs with acute experimental allergic encephalomyelitis (EAE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

Immunomodulating activity of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900318-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00318-0

1 reference

1 December 2017

1 reference